Chembio Diagnostics
Founded in 1985, Chembio is a diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever, and tropical disease. The company's proprietary DPP technology platform, which uses a small drop of blood from the fingertip or alternative sample types, provides results in minutes. Chembio's products are sold globally, directly and through distributors, hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company's headquarters is in Medford, New York.
Last updated on
About Chembio Diagnostics
Founded
1986Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$31MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
HauppaugeState
New YorkCountry
United StatesChembio Diagnostics
Find your buyer within Chembio Diagnostics